Zobrazeno 1 - 10
of 172
pro vyhledávání: '"M, Nordlander"'
Publikováno v:
Acta Physiologica Scandinavica. 144:291-306
Folkow, B., Isaksson, O. G. P., Karlstrom, G., Lever, A. F. & Nordlander, M. 1992. Trophic effects of hypophyseal hormones on resistance vessels and the heart in normotensive and renal hypertensive rats. Acta Physiol Scand144, 291–306. Received 20
Publikováno v:
Journal of Cardiovascular Pharmacology. 18:S36-S41
Publikováno v:
Acta anaesthesiologica Scandinavica. 44(2)
Background: The aim was to evaluate the use of clevidipine, a new vascular selective, ultra-short-acting calcium antagonist for blood pressure control after coronary artery bypass grafting (CABG). Methods: The effects of clevidipine on central hemody
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 27(5)
Clevidipine is a new vascular selective calcium channel antagonist of the dihydropyridine type, structurally related to felodipine. Clinical trials have shown that the drug can be used to effectively control the blood pressure in connection with card
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 268(3)
We compared the effects of three dihydropyridine calcium antagonists (felodipine, nifedipine and amlodipine) on left ventricular (LV) contractile performance and diastolic filling dynamics in eight conscious animals. After administering metoprolol an
Autor:
M, Nordlander, N, Havu
Publikováno v:
Kidney international. Supplement. 36
To investigate if blood pressure reduction per se may prevent progressive renal disease in aging spontaneously hypertensive rats (SHR), 15-month-old SHR were treated with the calcium antagonist felodipine, with the beta-blocker metoprolol or with the
Publikováno v:
Kidney international. Supplement. 36
Felodipine is a dihydropyridine calcium antagonist which lowers total peripheral resistance and blood pressure in doses which have no effect on cardiac conduction and contractility. It increases the urinary excretion of sodium and water due to decrea
Publikováno v:
Arteriosklerotische Gefäßerkrankungen ISBN: 9783528078416
Basierend auf Ergebnissen aus Studien menschlicher und experimenteller Atherosklerose wird angenommen, das die fruhe Atherogenese durch folgende Ereignisse gekennzeichnet ist: 1. Anhaufung von mononuklearen Zellen, insbesondere Makrophagen, in der ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a719a0779e8d6487b3528943543d2f5
https://doi.org/10.1007/978-3-663-19646-4_44
https://doi.org/10.1007/978-3-663-19646-4_44
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.